Clinical Trials Sponsored by Jonathan Gerber

Total 1845 results

Emory University
The Gerber Foundation

Completed

Effect of Probiotic Supplementation on Immune Function in Healthy Infants (ProBoost)

Inflammation

United States
Vanderbilt University
The Gerber Foundation

Completed

Neurodevelopment and Neuroimaging in Parenterally-fed Infants and Young Children

Necrotizing Enterocolitis | Cholestasis | Digestive System Abnormalities | Parenteral Nutrition

United States
Georgetown University
The Gerber Foundation

Completed

Study to Investigate the Potential of Probiotics in Yogurt (SIPPY)

Healthy

United States
Isabelle Herter-Aeberli
Berner Fachhochschule

Recruiting

Development and Evaluation of a Web-based Diet Quality Screener for Vegans (VEGANScreener) (VEGANScreener)

Healthy

Switzerland
Nathan Kline Institute for Psychiatric Research

Completed

D-serine and Cognitive Remediation in Schizophrenia

Schizophrenia

United States
Aruna Nathan
Children's Hospital of Philadelphia

Terminated

Sedation With Dexmedetomidine During Cardiac Catheterization

Pulmonary Hypertension

United States
Nathan Bahary, MD

Completed

Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine

Pancreatic Cancer

United States
Nathan Bahary, MD

Terminated

Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer

Borderline Resectable Pancreatic Cancer

United States
Nathan Kline Institute for Psychiatric Research

Completed

Transcranial Direct Current Stimulation (tDCS) As A Treatment For Cigarette Craving and Cognitive Deficits in Schizophrenic (TDCSSCHIZ)

Schizophrenia | Cognition | Cigarette Smoking

United States
Gerbera Therapeutics, Inc.

Not yet recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression (NuMom)

Postpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal Depression

United States
Nathan Kline Institute for Psychiatric Research

Completed

Clozapine and Olanzapine Treatment of Aggression

Schizophrenia

United States
Jonathan Friedberg
National Cancer Institute (NCI); National Institutes of Health (NIH)

Active, not recruiting

A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma (ILyAD)

Follicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Mucosal-Associated Lymphoid Tissue Lymphoma

United States
Boston Children's Hospital
The Gerber Foundation

Completed

Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease (SUPPRESS-CHD)

Congenital Heart Disease | Infection | Upper Gastrointestinal Bleeding | Stress Ulcer

United States
Montefiore Medical Center
The Gerber Foundation

Completed

Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants

Prematurity | Neurodevelopmental Disorder | Carnitine Deficiency

United States
University of Miami
The Gerber Foundation

Completed

Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants

Apnea of Prematurity | Periodic Breathing | Desaturation of Blood | Central Apnea | Obstructive Apnea of Newborn

United States
University of Virginia
The Gerber Foundation

Unknown

Safety and Tolerability of Lactoferrin/FOS in Very Low Birth Weight Infants

Tolerance | Safety Issues | Very Low Birth Weight Infant
University of Virginia
The Gerber Foundation

Unknown

Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants

Very Low Birth Weight Infants

United States
University of Michigan
The Gerber Foundation

Completed

Impact of Behavioral Feeding Intervention on Parent-Child Attachment in Young Children

Pediatric Feeding Disorders

United States
University of Florida
The Gerber Foundation

Completed

Effects Of Not Measuring Gastric Residual Content On Feeding Tolerance In Premature Infants iNFANTS

Premature Infant

United States
Guerbet

Not yet recruiting

Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT Examination

Patient Participation
Guerbet

Completed

Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRI

Pediatric Patients | Central Nervous System Indication | Body Indication

Bulgaria, Hungary, Poland, Slovakia, Ukraine
Guerbet

Completed

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Blood Brain Barrier Defect | CNS Lesion

Korea, Republic of, United States, Czechia, Italy, Belgium, Poland, Hungary, Mexico
Guerbet

Unknown

Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization. (In-Live)

Hemangioendothelioma | Angiosarcoma | Congenital Hemangioma | Arteriovenous Malformation

India
Guerbet

Completed

Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function

Renal Insufficiency | Healthy Volunteers

Moldova, Republic of, Romania
Guerbet

Completed

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions (SENTIO)

Central Nervous System Diseases | Diagnostic Self Evaluation

United States, Korea, Republic of, Argentina, Spain, France, Austria, Germany, Brazil, Chile, Italy, United Kingdom
Guerbet

Terminated

Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography (CINOPSIS CT)

Renal Impairment

United States
Guerbet

Withdrawn

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection (SHERLOC)

Renal Insufficiency | Nephrogenic Systemic Fibrosis

United States
Guerbet

Completed

Post-marketing Surveillance Study for Evaluation of Dotarem Safety

Contrast-enhanced MRI With Dotarem
Guerbet

Completed

Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography

MR Mammography With Dotarem
Guerbet

Completed

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors (REMIND)

Primary Brain Tumor

Colombia, Korea, Republic of, United States, Mexico
Guerbet

Completed

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Cerebral Arterial Diseases

United States
Guerbet

Completed

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Cerebral Arterial Diseases

United States
Guerbet

Terminated

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

Renal Artery Stenosis

United States
Guerbet

Completed

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography (X-ACT)

Coronary Artery Disease

Spain, France, Germany, Italy, Switzerland
Guerbet

Completed

Safety and Dialysability of Dotarem® in Dialysed Patients

End-stage Renal Failure

Belgium
Guerbet

Completed

DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases

Peripheral Arterial Disease

France
Guerbet

Completed

A Clinical Study of Iobitridol in Patients Undergoing Multislice Computed Tomography (CT) Abdominal Angiography

Diagnostic Imaging

Austria, France
University of Florida
The Gerber Foundation

Recruiting

Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit

Bronchopulmonary Dysplasia | Ventilator Associated Pneumonia | Respiratory Disease

United States
University of Michigan
The Gerber Foundation

Recruiting

Predicting Peanut Anaphylaxis and Reducing Epinephrine (PrePARE)

Anaphylaxis Food

United States
Wayne State University
The Gerber Foundation

Terminated

Early Versus Late Caffeine for ELBW Newborns

Bronchopulmonary Dysplasia | Apnea of Prematurity

United States
Virginia Commonwealth University
The Gerber Foundation

Completed

Decreasing Antibiotic Use in Infants With Suspected Ventilator-associated Infection (VAIN2)

Microbial Colonization | Ventilator Associated Pneumonia | Nosocomial Infections in Children

United States, Canada
Nathan Kline Institute for Psychiatric Research

Completed

Pioglitazone as a Treatment for Lipid and Glucose Abnormalities In Patients With Schizophrenia

Diabetes | Schizophrenia | Cognitive Impairment | Insulin Resistance

United States
Nathan Kline Institute for Psychiatric Research

Completed

Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors

Schizophrenia | Cigarette Smoking

United States, China, Israel
Nathan Kline Institute for Psychiatric Research

Terminated

Metformin for Weight Loss in Schizophrenia

Obesity | Schizophrenia

United States
Nathan Kline Institute for Psychiatric Research

Completed

Biomarkers in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Nathan Kline Institute for Psychiatric Research

Terminated

Conversion to Antipsychotic Monotherapy (MOPE)

Schizophrenia | Schizoaffective Disorder
Guerbet

Recruiting

Safety and Performance of Vectorio® in Conventional Trans-Arterial Chemo-Embolization (cTACE): A Post-Market Clinical Follow-up

Oncology

Austria, France, Switzerland
Guerbet

Completed

Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis

Chronic Liver Disease | HepatoCellular Carcinoma

France
Guerbet

Completed

Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers

Pharmacokinetics

Japan
Guerbet

Completed

Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) (PICTURE)

Blood Brain Barrier Defect | CNS Lesion

United States, Spain, Korea, Republic of, Taiwan, France, Hungary, Belgium, Germany, Italy, Mexico, Poland

Clinical Trials Sponsored by Jonathan Gerber

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations